Facebook Linkedin X-twitter

About Us

Leadership Team

Core Team

Ce‑Kuen Shieh, Ph.D. — Chairman

Director General, National Center for High‑Performance Computing (NCHC); Associate Dean, College of Electrical & Computer Science, NCKU; Chair, Department of Electrical Engineering, NCKU; Director, Computer & Network Center, NCKU

Jim Wang — Special Assistant

20+ years in biotech product development & market expansion

M.C. James Wu — Business Development Manager

8+ years in biotech and startup business development

Y.C. Sonia Lin — Regulatory Affairs Manager


10+ years in clinical operations & regulatory affairs

Yu‑Lin Mau, Ph.D. — Data Scientist

5+ years in biostatistics & data analytics

Advisors

Yi‑Shan Tsai, M.D. — Associate Professor

Chief, Department of Medical Imaging, National Cheng Kung University; Director, Clinical Innovation and Research Center, National Cheng Kung University and Hospital

Yu‑Hsuan Lai, M.D., Ph.D. — Assistant Professor

Clinical Assistant Professor, Division of Radiation Oncology, Department of Oncology, National Cheng Kung University Hospital; Attending Physician, Clinical Innovation and Research Center, National Cheng Kung University Hospital

Stone Weng — Operations Advisor

Managing Partner, Infinio Capital; GP, ETSF1 Technology Fund; Mentor, NCKU Phoenix Accelerator

Casey Yeh — Advisor

NCKU Hospital Clinical Innovation R&D Center; former Director of Software Development at VISA; R&D lead for Autodesk cloud platform; Chief Innovation Officer at CTCI

Po‑Chun Kuo, Ph.D.— Associate Professor

National Yang Ming Chiao Tung University
— Computer Vision, Deep Learning, Medical Imaging AI, and Cloud-Edge Systems

Pei‑Fang Su, Ph.D. — Professor

Department of Statistics, NCKU — Survival Analysis, Statistical Consulting, Biostatistics

Dr. Chun‑Yi Lee, Ph.D.— Associate Professor

Department of Statistics, NCKU — Bioinformatics, Industrial Statistics, Statistical Computing, Consulting

Company Milestones

March — Company Founded

  • Core technology granted patent in Taiwan.
  • Our Abdominal CT Body Composition Quantification software has successfully achieved clearance as a Class II medical device by the TFDA. Additionally, it was honored with the 20th National Innovation Award in the Clinical Innovation category for the “Abdominal CT Body Composition Quantification System.”
  • Winner of the 2024 National Innovation Enhancement Award — “Abdominal CT Body Composition Quantification System”
2023

  • Our company has passed the inspection for compliance with the Medical Device Quality Management System Regulations (Certificate No. QMS2230).
  • Core technology granted patent in Japan.
  • Winner of the 2024 National Innovation Enhancement Award — “Abdominal CT Body Composition Quantification System”
2024

  • Core technology granted patent in the USA.
  • Core technology granted European (EPC) patent.
  • Approved by the Public Health Bureau of Tainan City Government as a self-pay medical item. (Ref. No. 1140120210)
  • Winner of the "AI Precision Prevention Award" at the 2025 Storm Media AI Healthcare Innovation Awards (AIHIA).
2025